CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$124.07 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2014-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-06-30 was -$133.41K, a 111.08% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-03-31 was $9.34K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-06-30 was $1.20M.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-03-31 was -$1.22M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month |
|---|---|---|
| 2014-06-30 | -$133.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$124.07K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $9.34K 10-Q · filed 2014-05-15 | |
| 2013-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$15.10K 10-Q · filed 2014-08-14 |
| 2013-03-31 | -$1.22M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |